Personalized Neo-antigen Vaccine in Advanced Solid Tumors (NeoPepVac)
NCT03715985
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Malignant Melanoma, Metastatic
Non Small Cell Lung Cancer Metastatic
Bladder Urothelial Carcinoma, Metastatic
Interventions
DRUG:
EVAX-01-CAF09b
Sponsor
Herlev Hospital